Syndax Pharmaceuticals, Inc. (SNDX)
8.72
-0.41
(-4.49%)
USD |
NASDAQ |
Nov 20, 16:00
8.73
+0.01
(+0.11%)
After-Hours: 20:00
Syndax Pharmaceuticals Cash and Short Term Investments (Annual) : 394.07M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 394.07M |
| December 31, 2024 | 572.88M |
| December 31, 2023 | 570.70M |
| December 31, 2022 | 475.80M |
| December 31, 2021 | 440.05M |
| December 31, 2020 | 293.18M |
| December 31, 2019 | 59.78M |
| December 31, 2018 | 81.01M |
| Date | Value |
|---|---|
| December 31, 2017 | 130.08M |
| December 31, 2016 | 105.48M |
| December 31, 2015 | 86.54M |
| December 31, 2014 | 12.14M |
| December 31, 2013 | 14.31M |
| December 31, 2012 | 0.711M |
| December 31, 2011 | 4.314M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Emergent BioSolutions, Inc. | 209.10M |
| Incyte Corp. | 3.581B |
| Vertex Pharmaceuticals, Inc. | 6.611B |
| Travere Therapeutics, Inc. | 322.80M |